Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/taylor-francis/evidence-for-differences-in-regioselective-and-stereoselective-Tbdr0WydZm
References (37)
-
Tony Kiang, M. Ensom, Thomas Chang (2005)
UDP-glucuronosyltransferases and clinical drug-drug interactions.Pharmacology & therapeutics, 106 1
-
P. Kosina, P. Maurel, J. Ulrichová, Z. Dvořák (2005)
Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytesJournal of Biochemical and Molecular Toxicology, 19
-
O. Kerdpin, K. Knights, D. Elliot, J. Miners (2008)
In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.Biochemical pharmacology, 76 2
-
D. Josephy, P. Guengerich, J. Miners (2005)
“Phase I and Phase II” Drug Metabolism: Terminology that we Should Phase Out?Drug Metabolism Reviews, 37
-
H. Isom, T. Secott, I. Georgoff, C. Woodworth, J. Mummaw (1985)
Maintenance of differentiated rat hepatocytes in primary culture.Proceedings of the National Academy of Sciences of the United States of America, 82 10
-
John Cashman, Beatrice Perotti, Clifford Berkman, Jing Lin (1996)
Pharmacokinetics and molecular detoxication.Environmental Health Perspectives, 104
-
D.R Jones, J. Moran, G. Miller (2009)
Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolismDrug Metabolism Reviews, 42
-
R. Lewinsky, P. Smith, P. Mackenzie (2005)
Glucuronidation of bioflavonoids by human UGT1A10: structure–function relationshipsXenobiotica, 35
-
P. Gregory, R. Lewinsky, D. Gardner-Stephen, P. Mackenzie (2004)
Regulation of UDP glucuronosyltransferases in the gastrointestinal tract.Toxicology and applied pharmacology, 199 3
-
V. Křen, R. Gažák, K. Purchartová, P. Marhol, D. Biedermann, P. Sedmera (2009)
Chemoenzymatic preparative separation of silybins A and BJournal of Molecular Catalysis B-enzymatic, 61
-
Y. Han, H. Lou, D. Ren, L. Sun, B. Ma, M. Ji (2004)
Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process.Journal of pharmaceutical and biomedical analysis, 34 5
-
(2002)
Use of long-term cultures of human hepatocytes -
C. Sridar, T. Goosen, U. Kent, J. Williams, P. Hollenberg (2004)
Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.Drug metabolism and disposition: the biological fate of chemicals, 32 6
-
L. Pichard‐Garcia, S. Gerbal-Chaloin, J. Ferrini, J. Fabre, P. Maurel (2002)
Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression.Methods in enzymology, 357
-
R. Tukey, C. Strassburg (2000)
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.Annual review of pharmacology and toxicology, 40
-
R. Gažák, P. Marhol, K. Purchartová, D. Monti, D. Biedermann, S. Riva, L. Cvak, V. Křen (2010)
Large-scale separation of silybin diastereoisomers using lipasesProcess Biochemistry, 45
-
V. Kukongviriyapan, N. Phromsopha, W. Tassaneeyakul, U. Kukongviriyapan, B. Sripa, V. Hahnvajanawong, V. Bhudhisawasdi (2006)
Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2Xenobiotica, 36
-
V. Křen, J. Ulrichová, P. Kosina, D. Stevenson, P. Sedmera, V. Přikrylová, P. Halada, V. Šimánek (2000)
Chemoenzymatic preparation of silybin beta-glucuronides and their biological evaluation.Drug metabolism and disposition: the biological fate of chemicals, 28 12
-
Zhiming Wen, Todd Dumas, S. Schrieber, R. Hawke, M. Fried, Philip Smith (2008)
Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle ExtractDrug Metabolism and Disposition, 36
-
T. Flaig, M. Glodé, D. Gustafson, A. Bokhoven, Y. Tao, Shandra Wilson, L. Su, Yuan Li, G. Harrison, R. Agarwal, E. Crawford, M. Lucia, M. Pollak (2010)
A study of high‐dose oral silybin‐phytosome followed by prostatectomy in patients with localized prostate cancerThe Prostate, 70
-
Peter Mackenzie (2000)
Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid.Therapeutic drug monitoring, 22 1
-
R. Gažák, D. Walterová, V. Křen (2007)
Silybin and silymarin--new and emerging applications in medicine.Current medicinal chemistry, 14 3
-
Jhy-Wen Wu, Lie-Chwen Lin, Shih-Chieh Hung, Chi-Hung Lin, C. Chi, T. Tsai (2008)
Hepatobiliary Excretion of Silibinin in Normal and Liver Cirrhotic RatsDrug Metabolism and Disposition, 36
-
Yakun Chen, Shenggu Xie, Shuqing Chen, S. Zeng (2008)
Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9.Biochemical pharmacology, 76 3
-
J. Miners, P. Mackenzie, K. Knights (2010)
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potentialDrug Metabolism Reviews, 42
-
Y. Wong, Li Zhang, G. Lin, Z. Zuo (2009)
Structure–activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferasesExpert Opinion on Drug Metabolism & Toxicology, 5
-
Yang Han, Dong Guo, Yao Chen, Z. Tan, Hong-Hao Zhou (2009)
Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteersXenobiotica, 39
-
K. Knights, J. Miners (2010)
Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediatorsDrug Metabolism Reviews, 42
-
C. Strassburg, N. Nguyễn, M. Manns, R. Tukey (1998)
Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.Molecular pharmacology, 54 4
-
K. Knights, L. Winner, D. Elliot, K. Bowalgaha, J. Miners (2009)
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.British journal of clinical pharmacology, 68 3
-
P. Jančová, E. Anzenbacherová, B. Papoušková, K. Lemr, P. Lužná, Alena Veinlichová, P. Anzenbacher, V. Šimánek (2007)
Silybin Is Metabolized by Cytochrome P450 2C8 in VitroDrug Metabolism and Disposition, 35
-
R. Tukey, C. Strassburg (2001)
Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.Molecular pharmacology, 59 3
-
C. Strassburg, Karl Oldhafer, M. Manns, R. Tukey (1997)
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.Molecular pharmacology, 52 2
-
B. Gaiser, D. Lockley, A. Staines, C. Baarnhielm, B. Burchell (2003)
Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7Xenobiotica, 33
-
Ziqiang Cheng, A. Radomińska-Pandya, T. Tephly (1999)
Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.Drug metabolism and disposition: the biological fate of chemicals, 27 10
-
W. Baer-Dubowska, H. Szaefer, V. Krajka-Kuźniak (1998)
Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds.Xenobiotica; the fate of foreign compounds in biological systems, 28 8
-
A. Bartholomaeus, R. Bolton, J. Ahokas (1994)
Inhibition of rat liver cytosolic glutathione S-transferase by silybin.Xenobiotica; the fate of foreign compounds in biological systems, 24 1
- Publisher
- Taylor & Francis
- Copyright
- © 2011 Informa UK, Ltd.
- ISSN
- 1366-5928
- eISSN
- 0049-8254
- DOI
- 10.3109/00498254.2011.573017
- pmid
- 21524189
- Publisher site
- See Article on Publisher Site
Abstract
The flavonolignan silybin, the main component of silymarin, extract from the seeds of Silybum marianum, is used mostly as a hepatoprotectant. Silybin is almost 1:1 mixture of two diastereomers A and B. The individual UDP-glucuronosyltransferases (UGTs) contributing to the metabolism of silybin diastereomers have not been identified yet. In this study, the contribution of UGTs to silybin metabolism was examined.The potential silybin metabolites were formed in vitro by incubating silybin (i) with the human liver microsomal fraction, (ii) with human hepatocytes and finally (iii) with 12 recombinant UGTs (UGT1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B15 and 2B17). High-performance liquid chromatographic (HPLC) techniques with UV detection and additionally MS detection were used for metabolite identification.Hepatocytes and microsomes formed silybin A-7-O-β-d-glucuronides, B-7-O-β-d-glucuronides, A-20-O-β-d-glucuronides and B-20-O-β-d-glucuronides. With recombinant UGTs, the major role of the UGT1A1, 1A3, 1A8 and 1A10 enzymes but also of the UGT1A6, 1A7, 1A9, 2B7 and 2B15 in the stereoselective reactions leading to the respective silybin glucuronides was confirmed. UGT1A4, UGT2B4 and UGT2B17 did not participate in silybin glucuronidation.The predominant formation of 7-O-β-d-glucuronides and the preferential glucuronidation of silybin B diastereomer in vitro by human UGTs were confirmed.
Journal
Xenobiotica – Taylor & Francis
Published: Sep 1, 2011
Keywords: Silybin; conjugation; metabolism; HPLC; UGT; regioselectivity; stereoselectivity